Hourglass Capital’s Elevance Health ELV Stock Holding History

Hourglass Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,200	Closed	-$458K	–	116
2021 Q2	$458K	Hold	1,200	–	–	0.11%	103
2021 Q1	$431K	Hold	1,200	–	–	0.11%	100
2020 Q4	$385K	Hold	1,200	–	–	0.11%	101
2020 Q3	$322K	Hold	1,200	–	–	0.11%	99
2020 Q2	$316K	Hold	1,200	–	–	0.11%	98
2020 Q1	$272K	Hold	1,200	–	–	0.12%	93
2019 Q4	$362K	Hold	1,200	–	–	0.1%	88
2019 Q3	$288K	Hold	1,200	–	–	0.08%	90
2019 Q2	$339K	Hold	1,200	–	–	0.1%	80
2019 Q1	$344K	Hold	1,200	–	–	0.1%	79
2018 Q4	$315K	Hold	1,200	–	–	0.1%	90
2018 Q3	$329K	Hold	1,200	–	–	0.09%	91
2018 Q2	$286K	Hold	1,200	–	–	0.07%	93
2018 Q1	$264K	Sell	1,200 -7,228	-86%	-$1.7M	0.06%	101
2017 Q4	$1.9M	Sell	8,428 -289	-3%	-$61.6K	0.43%	57
2017 Q3	$1.66M	Hold	8,717	–	–	0.39%	57
2017 Q2	$1.64M	Sell	8,717 -4,100	-32%	-$737K	0.41%	55
2017 Q1	$2.12M	Sell	12,817 -100	-0.8%	-$15.9K	0.51%	55
2016 Q4	$1.86M	Sell	12,917 -6,570	-34%	-$880K	0.46%	56
2016 Q3	$2.44M	Sell	19,487 -70	-0.4%	-$9.04K	0.61%	53
2016 Q2	$2.57M	Hold	19,557	–	–	0.64%	55
2016 Q1	$2.72M	Sell	19,557 -830	-4%	-$111K	0.69%	55
2015 Q4	$2.84M	Sell	20,387 -420	-2%	-$57.9K	0.74%	49
2015 Q3	$2.91M	Sell	20,807 -35	-0.2%	-$5.26K	0.64%	55
2015 Q2	$3.42M	Sell	20,842 -30,974	-60%	-$4.95M	0.54%	59
2015 Q1	$8M	Sell	51,816 -8,315	-14%	-$1.18M	1.2%	23
2014 Q4	$7.56M	Sell	60,131 -8,504	-12%	-$1.05M	1.36%	23
2014 Q3	$8.21M	Sell	68,635 -1,128	-2%	-$129K	1.09%	22
2014 Q2	$7.51M	Sell	69,763 -11,219	-14%	-$1.16M	1.09%	28
2014 Q1	$8.06M	Buy	+80,982	New	+$7.32M	1.34%	25

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Hourglass Capital's ELV Position: Q3 2021 in Review

Hourglass Capital sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 1,200 shares — an estimated $458K sold.

Hourglass Capital first reported a position in ELV in Q1 2014 and held it in 30 quarters. The position peaked at $8.21M in Q3 2014. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

Hourglass Capital reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
Hourglass Capital sold 1,200 Elevance Health shares in Q3 2021, an estimated $458K.
Hourglass Capital first reported a position in Elevance Health in Q1 2014 and held it in 30 quarters.
Hourglass Capital's Elevance Health position peaked at $8.21M in Q3 2014.
1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Hourglass Capital's 13F filing for Q3 2021, filed 12 Nov 2021.